BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Todd JJ, Lawal TA, Witherspoon JW, Chrismer IC, Razaqyar MS, Punjabi M, Elliott JS, Tounkara F, Kuo A, Shelton MO, Allen C, Cosgrove MM, Linton M, Michael D, Jain MS, Waite M, Drinkard B, Wakim PG, Dowling JJ, Bönnemann CG, Emile-Backer M, Meilleur KG. Randomized controlled trial of N-acetylcysteine therapy for RYR1-related myopathies. Neurology 2020;94:e1434-44. [PMID: 31941795 DOI: 10.1212/WNL.0000000000008872] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Greer LK, Meilleur KG, Harvey BK, Wires ES. Identification of ER/SR resident proteins as biomarkers for ER/SR calcium depletion in skeletal muscle cells. Orphanet J Rare Dis 2022;17:225. [PMID: 35698232 DOI: 10.1186/s13023-022-02368-9] [Reference Citation Analysis]
2 Endo Y, Groom L, Celik A, Kraeva N, Lee CS, Jung SY, Gardner L, Shaw MA, Hamilton SL, Hopkins PM, Dirksen RT, Riazi S, Dowling JJ. Variants in ASPH cause exertional heat illness and are associated with malignant hyperthermia susceptibility. Nat Commun 2022;13:3403. [PMID: 35697689 DOI: 10.1038/s41467-022-31088-8] [Reference Citation Analysis]
3 Ogasawara M, Nishino I. A review of major causative genes in congenital myopathies. J Hum Genet 2022. [PMID: 35668205 DOI: 10.1038/s10038-022-01045-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Gómez-Oca R, Cowling BS, Laporte J. Common Pathogenic Mechanisms in Centronuclear and Myotubular Myopathies and Latest Treatment Advances. Int J Mol Sci 2021;22:11377. [PMID: 34768808 DOI: 10.3390/ijms222111377] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
5 Beaufils M, Travard L, Rendu J, Marty I. Therapies for RYR1-Related Myopathies: Where We Stand and the Perspectives. Curr Pharm Des 2021. [PMID: 34514983 DOI: 10.2174/1389201022666210910102516] [Reference Citation Analysis]
6 Capella-Peris C, Cosgrove MM, Chrismer IC, Razaqyar MS, Elliott JS, Kuo A, Emile-Backer M, Meilleur KG. Understanding Symptoms in RYR1-Related Myopathies: A Mixed-Methods Analysis Based on Participants' Experience. Patient 2020;13:423-34. [PMID: 32329019 DOI: 10.1007/s40271-020-00418-7] [Reference Citation Analysis]
7 Mosca N, Petrillo S, Bortolani S, Monforte M, Ricci E, Piemonte F, Tasca G. Redox Homeostasis in Muscular Dystrophies. Cells 2021;10:1364. [PMID: 34205993 DOI: 10.3390/cells10061364] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
8 Zito E, Ferreiro A. Calcium and Redox Liaison: A Key Role of Selenoprotein N in Skeletal Muscle. Cells 2021;10:1116. [PMID: 34066362 DOI: 10.3390/cells10051116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Lawal TA, Patankar A, Todd JJ, Razaqyar MS, Chrismer IC, Zhang X, Waite MR, Jain MS, Emile-Backer M, Witherspoon JW, Liu CY, Grunseich C, Meilleur KG. Ryanodine Receptor 1-Related Myopathies: Quantification of Intramuscular Fatty Infiltration from T1-Weighted MRI. J Neuromuscul Dis 2021;8:657-68. [PMID: 33646171 DOI: 10.3233/JND-200549] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Lawal TA, Todd JJ, Witherspoon JW, Bönnemann CG, Dowling JJ, Hamilton SL, Meilleur KG, Dirksen RT. Ryanodine receptor 1-related disorders: an historical perspective and proposal for a unified nomenclature. Skelet Muscle 2020;10:32. [PMID: 33190635 DOI: 10.1186/s13395-020-00243-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
11 García-Campos P, Báez-Matus X, Jara-Gutiérrez C, Paz-Araos M, Astorga C, Cea LA, Rodríguez V, Bevilacqua JA, Caviedes P, Cárdenas AM. N-Acetylcysteine Reduces Skeletal Muscles Oxidative Stress and Improves Grip Strength in Dysferlin-Deficient Bla/J Mice. Int J Mol Sci 2020;21:E4293. [PMID: 32560255 DOI: 10.3390/ijms21124293] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Volpatti JR, Endo Y, Knox J, Groom L, Brennan S, Noche R, Zuercher WJ, Roy P, Dirksen RT, Dowling JJ. Identification of drug modifiers for RYR1-related myopathy using a multi-species discovery pipeline. Elife 2020;9:e52946. [PMID: 32223895 DOI: 10.7554/eLife.52946] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
13 Harandi VM, Oliveira BMS, Allamand V, Friberg A, Fontes-Oliveira CC, Durbeej M. Antioxidants Reduce Muscular Dystrophy in the dy2J/dy2J Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy. Antioxidants (Basel) 2020;9:E244. [PMID: 32197453 DOI: 10.3390/antiox9030244] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]